Disease | dermatomyositis |
Phenotype | C0024115|lung disease |
Sentences | 23 |
PubMedID- 25698373 | Rapidly progressive interstitial lung disease (rp-ild) in patients with clinically amyopathic dermatomyositis (cadm) associated with antibodies to melanoma differentiation-associated gene5 (mda5) results in a high mortality rate. |
PubMedID- 25346167 | Anti-transcription intermediary factor 1-gamma antibody-positive clinically amyopathic dermatomyositis complicated by interstitial lung disease and breast cancer. |
PubMedID- 22931947 | [clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease]. |
PubMedID- 20506189 | Conclusion: these promising data indicate that mycophenolate mofetil may be a useful therapy for interstitial lung disease in patients with dermatomyositis, but larger studies are needed to more definitively evaluate the role of this medication in therapy. |
PubMedID- 26328651 | Rapidly progressive interstitial lung disease associated with dermatomyositis treated with combination of immunosuppressive therapy, direct hemoperfusion with a polymyxin b immobilized fiber column and intravenous immunoglobulin. |
PubMedID- 25888887 | Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis. |
PubMedID- 22863719 | Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases. |
PubMedID- 23569020 | Objective: : to study the clinical features of interstitial lung disease (ild) in patients with dermatomyositis and factors related to its development. |
PubMedID- 23423441 | This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease. |
PubMedID- 23158422 | Objective: to explore the possible diagnostic values of serum surfactant protein-a (sp-a) and surfactant protein-d (sp-d) for interstitial lung diseases (ild) in patients with polymyositis or dermatomyositis (pm/dm). |
PubMedID- 20827201 | A rare form of ild with a very poor prognosis, acute and rapidly progressive lung disease, is strongly associated with clinically amyopathic dermatomyositis (cadm) and a novel - anti-cadm-140 auto-antibody. |
PubMedID- 24142786 | [interstitial lung disease in patients with polymyositis and dermatomyositis--report of three cases]. |
PubMedID- 23983712 | He was suspected of rapidly progressing interstitial lung disease with dermatomyositis and transferred to our hospital. |
PubMedID- 20800454 | Serum tarc/ccl17 levels are increased in dermatomyositis associated with interstitial lung disease. |
PubMedID- 21748914 | Subsequently, a diagnosis of amyopathic dermatomyositis with interstitial lung disease and pneumomediastinum was made. |
PubMedID- 26459323 | Serum il8 and mrna level of cd11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease. |
PubMedID- 22781896 | [a clinical analysis of dermatomyositis with interstitial lung disease in 20 patients]. |
PubMedID- 26101728 | Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. |
PubMedID- 25622670 | Objective: to explore the clinical features and prognosis of dermatomyositis patients with interstitial lung disease (ild) as an initial manifestation. |
PubMedID- 23400027 | Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia. |
PubMedID- 24325117 | Objective: to investigate the clinical features and risk factors associated with interstitial lung disease (ild) in patients with classic dermatomyositis (classic dm) or clinical amyopathic dermatomyositis (cadm). |
PubMedID- 25433590 | [interstitial lung disease-associated with amyopathic dermatomyositis and anti-mda5 autoantibodies]. |
PubMedID- 22325787 | Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease. |
Page: 1